Rocket Pharmaceuticals Inc
NASDAQ:RCKT

Watchlist Manager
Rocket Pharmaceuticals Inc Logo
Rocket Pharmaceuticals Inc
NASDAQ:RCKT
Watchlist
Price: 2.7 USD -4.59% Market Closed
Market Cap: 290.9m USD

Intrinsic Value

RCKT's intrinsic value estimate is unreliable because it is based only on its DCF value and doesn't use a relative valuation using multiples.

The intrinsic value of one RCKT stock under the Base Case scenario is 2.24 USD. Compared to the current market price of 2.7 USD, Rocket Pharmaceuticals Inc is Overvalued by 17%.

The Intrinsic Value is calculated as the average of DCF and Relative values:

RCKT Intrinsic Value
2.24 USD
Overvaluation 17%
Intrinsic Value
Price
Base Case Scenario

Valuation History
Rocket Pharmaceuticals Inc

Valuation History Unavailable

Historical valuation for RCKT cannot be conducted due to limitations such as insufficient data or other constraints.

Valuation In Progress...
Valuation In Progress...
0%
Compare RCKT to

Fundamental Analysis

Company Overview
Loading...
Business Segments
Loading...
Earnings Call
Loading...
Management
Loading...
Contacts
Loading...
How do you feel about RCKT?
Bearish
Neutral
Bullish
AI Assistant
AI Assistant
Ask me anything about Rocket Pharmaceuticals Inc
Financials
Annual
Quarterly
TTM

Balance Sheet Decomposition
Rocket Pharmaceuticals Inc

Current Assets 324.5m
Cash & Short-Term Investments 318.2m
Other Current Assets 6.3m
Non-Current Assets 146.6m
PP&E 80.4m
Intangibles 64.3m
Other Non-Current Assets 1.9m
Efficiency

Free Cash Flow Analysis
Rocket Pharmaceuticals Inc

Last Value
3-Years Average
FCF Margin
Conversion Rate

Earnings Waterfall
Rocket Pharmaceuticals Inc

Revenue
0 USD
Operating Expenses
-270.2m USD
Operating Income
-270.2m USD
Other Expenses
12.2m USD
Net Income
-258m USD
Fundamental Scores

RCKT Profitability Score
Profitability Due Diligence

Rocket Pharmaceuticals Inc's profitability score is 24/100. The higher the profitability score, the more profitable the company is.

24/100
Profitability
Score

Rocket Pharmaceuticals Inc's profitability score is 24/100. The higher the profitability score, the more profitable the company is.

RCKT Solvency Score
Solvency Due Diligence

Rocket Pharmaceuticals Inc's solvency score is 73/100. The higher the solvency score, the more solvent the company is.

Short-Term Solvency
Long-Term Solvency
Negative Net Debt
Low D/E
73/100
Solvency
Score

Rocket Pharmaceuticals Inc's solvency score is 73/100. The higher the solvency score, the more solvent the company is.

Wall St
Price Targets

RCKT Price Targets Summary
Rocket Pharmaceuticals Inc

Wall Street analysts forecast RCKT stock price to rise over the next 12 months.

According to Wall Street analysts, the average 1-year price target for RCKT is 13.15 USD with a low forecast of 2.02 USD and a high forecast of 38.85 USD.

Lowest
Price Target
2.02 USD
25% Downside
Average
Price Target
13.15 USD
387% Upside
Highest
Price Target
38.85 USD
1 339% Upside
View Analyst Estimates
View Analyst Estimates

Dividends

Rocket Pharmaceuticals Inc
does not pay dividends
Shareholder Yield

Current shareholder yield for RCKT is .

Shareholder yield represents the total return a company provides to its shareholders, calculated as the sum of dividend yield, buyback yield, and debt paydown yield. What is shareholder yield?

Shareholder Yield
Dividend Yield
No dividends
Buyback Yield
Lowest
Average
Highest
Debt Paydown Yield
Lowest
Average
Highest

Competitive Landscape

Company Market Cap Intrinsic Valuation Profitability Solvency Price Change
1Y 3Y 5Y

Ownership

RCKT Insider Trading
Buy and sell transactions by insiders

RCKT News

Other Videos
What is the Intrinsic Value of one RCKT stock?

The intrinsic value of one RCKT stock under the Base Case scenario is 2.24 USD.

Is RCKT stock undervalued or overvalued?

Compared to the current market price of 2.7 USD, Rocket Pharmaceuticals Inc is Overvalued by 17%.

Back to Top